miRNAs can increase the efficiency of ex vivo platelet generation Stephan EmmrichKerstin HenkeJan-Henning Klusmann Original Article 05 July 2012 Pages: 1673 - 1684
Platelet activation and platelet–leukocyte interaction in β-thalassemia/hemoglobin E patients with marked nucleated erythrocytosis Rassamon KeawvichitLadawan KhowawisetsutKovit Pattanapanyasat Original Article 31 July 2012 Pages: 1685 - 1694
Molecular mechanisms of a novel β-thalassaemia mutation due to the duplication of tetranucleotide ‘AGCT’ at the junction IVS-II/exon 3 Gennaro MusollinoGabriella MastrolonardoGiuseppina Lacerra Original Article 24 July 2012 Pages: 1695 - 1701
FLT3 and NPM1 mutations in a cohort of AML patients and detection of a novel mutation in tyrosine kinase domain of FLT3 gene from Western India Kanjaksha GhoshSuchitra SwaminathanBaburao Vundinti Original Article 26 June 2012 Pages: 1703 - 1712
Activating CBL mutations are associated with a distinct MDS/MPN phenotype Juliana SchwaabThomas ErnstAndreas Reiter Original Article 10 August 2012 Pages: 1713 - 1720
Treatment of gastrointestinal diffuse large B cell lymphoma in China: a 10-year retrospective study of 114 cases Xiaoyang LiWeina ShenZhixiang Shen Original Article 26 June 2012 Pages: 1721 - 1729
The comparison between CHOP and R-CHOP in primary gastric diffuse large B cell lymphoma Byeong Seok SohnSun-Mok KimCheolwon Suh Original Article 03 July 2012 Pages: 1731 - 1739
Value of surveillance computed tomography in the follow-up of diffuse large B-cell and follicular lymphomas Tung-Liang LinMing-Chung KuoShu-Chen Lu Original Article 23 June 2012 Pages: 1741 - 1745
Prognostic relevance of pretreatment quality of life in diffuse large B-cell lymphoma patients treated with rituximab-CHOP: Results from a prospective cohort study Hyun Ae JungSilvia ParkWon Seog Kim Original Article 28 June 2012 Pages: 1747 - 1756
Study on effectiveness of gemcitabine, dexamethasone, and cisplatin (GDP) for relapsed or refractory AIDS-related non-Hodgkin's lymphoma Dong Ta ZhongChun Mei ShiJian Gang Liang Original Article 13 July 2012 Pages: 1757 - 1763
Current treatment of mantle cell lymphoma: results of a national survey and consensus meeting M. Witzens-HarigG. HessM. Dreyling Original Article 29 August 2012 Pages: 1765 - 1772
Low incidence of thromboembolism in relapsed/refractory myeloma patients treated with thalidomide without thromboprophylaxis in Taiwan Shang-Yin WuYu-Min YehTsai-Yun Chen Original Article 17 June 2012 Pages: 1773 - 1778
(Bortezomib plus lenalidomide/thalidomide)- vs (bortezomib or lenalidomide/thalidomide)-containing regimens as induction therapy in newly diagnosed multiple myeloma: a meta-analysis of randomized controlled trials Anyou WangQiaohong DuanZimin Sun Original Article 07 July 2012 Pages: 1779 - 1784
Radiotherapy for solitary plasmacytoma of bone and soft tissue Yang-Gun SuhChang-Ok SuhJaeho Cho Original Article 30 June 2012 Pages: 1785 - 1793
The use of adjusted ideal body weight for overweight patients undergoing HPC mobilisation for autologous transplantation C. HicksA. TrickettS. Ramanathan Original Article 27 July 2012 Pages: 1795 - 1801
Phytohemagglutinin-activated human T cells induce lethal graft-versus-host disease in cyclophosphamide and anti-CD122 conditioned NOD/SCID mice Yongxian HuYanjun GuHe Huang Original Article 15 June 2012 Pages: 1803 - 1812
ABL1 deletion without BCR/ABL1 rearrangement is originated from a large-sized 9q deletion Jungwon HuhYeung Chul MunWha Soon Chung Letter to the Editor 29 March 2012 Pages: 1813 - 1815
Primary mucosa-associated lymphoid tissue (MALT) lymphoma of the liver: clinical, molecular, and microbiological aspects Barbara KiesewetterLeonhard MüllauerMarkus Raderer Letter to the Editor 04 April 2012 Pages: 1817 - 1818
Usefulness of double-balloon enteroscopy for evaluation of duodenal follicular lymphoma Sho HangaiFumihiko NakamuraMineo Kurokawa Letter to the Editor 27 April 2012 Pages: 1819 - 1820
Primary intraocular lymphoma in a patient with systemic lupus erythematosus Feng Jung S. H. Woei-A-JinSabina KerstingJan Geert Bollemeijer Letter to the Editor Open access 03 May 2012 Pages: 1821 - 1822
Fasting glucose level reduction induced by imatinib in chronic myeloproliferative disease with TEL-PDGFRβ rearrangement and type 1 diabetes Adriano SalaroliGiuseppina LoglisciMassimo Breccia Letter to the Editor 24 May 2012 Pages: 1823 - 1824
Philadelphia-negative acute promyelocytic leukemia in a patient with chronic myeloid leukemia in complete cytogenetic response after treatment with tyrosine kinase inhibitor Kyoko InokuraYasushi OnishiHideo Harigae Letter to the Editor 29 April 2012 Pages: 1825 - 1826
Visceral leishmaniasis infection in a refractory multiple myeloma patient treated with bortezomib Eugenio PiroMariagrazia KroppStefano Molica Letter to the Editor 15 May 2012 Pages: 1827 - 1828
A novel frameshift mutation Gly239Serfs*8 in the PROC gene results in protein C deficiency in a Korean patient Sang Hyuk ParkSeongsoo JangYeon-Mok Oh Letter to the Editor 16 May 2012 Pages: 1829 - 1830
Deep vein thrombosis associated with factor V inhibitor followed by immune thrombocytopenia Takakazu HiguchiTakeshi OkamotoSadamu Okada Letter to the Editor 16 May 2012 Pages: 1831 - 1832